Plasma Amino Acids in Early Pregnancy and Midpregnancy and Their Interplay With Phospholipid Fatty Acids in Association With the Risk of Gestational Diabetes Mellitus: Results From a Longitudinal Prospective Cohort
Open Access
- 26 January 2023
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 46 (4) , 722-732
Abstract
OBJECTIVE: We prospectively evaluated plasma amino acids (AAs) in early pregnancy and midpregnancy and their interplay with phospholipid fatty acids (FAs) in association with gestational diabetes mellitus (GDM) risk.RESEARCH DESIGN AND METHODS: From a longitudinal pregnancy cohort of 2,802 individuals, concentrations of 24 plasma AAs at 10–14 and 15–26 gestational weeks (GW) were assessed among 107 GDM case subjects and 214 non-GDM control subjects. We estimated adjusted odds ratios (OR) and 95% CI for the associations of plasma AAs and the joint associations of plasma AAs and phospholipid FAs with GDM risk, adjusting for risk factors including age, prepregnancy BMI, and family history of diabetes.RESULTS: Glycine at 10–14 GW was inversely associated with GDM (adjusted OR [95% CI] per SD increment: 0.55 [0.39–0.79]). Alanine, aspartic acid, and glutamic acid at 10–14 GW were positively associated with GDM (1.43 [1.08–1.88], 1.41 [1.11–1.80], and 1.39 [0.98–1.98]). At 15–26 GW, findings for glycine, alanine, aspartic acid, and the glutamine–to–glutamic acid ratio were consistent with the directions observed at 10–14 GW. Isoleucine, phenylalanine, and tyrosine were positively associated with GDM (1.64 [1.19–2.27], 1.15 [0.87–1.53], and 1.56 [1.16–2.09]). All P values for linear trend were <0.05. Several AAs and phospholipid FAs were significantly and jointly associated with GDM. For instance, the lowest risk was observed among women with higher glycine and lower even-chain saturated FAs at 10–14 GW (adjusted OR [95% CI] 0.15 [0.06, 0.37]).CONCLUSIONS: Plasma AAs may be implicated in GDM development starting in early pregnancy. Associations of AAs with GDM may be enhanced in the copresence of phospholipid FA profile.Keywords
All Related Versions
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HHSN27500006, HHSN275200800002I, HHSN275200800003IC, HHSN275200800012C, HHSN275200800013C, HHSN275200800014C, HHSN275200800028C, HHSN275201000001Z, HHSN275201000009C)
This publication has 38 references indexed in Scilit:
- Plasma branched-chain and aromatic amino acid concentration after ingestion of an urban or rural diet in rural Mexican womenBMC Obesity, 2015
- Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort studyThe Lancet Diabetes & Endocrinology, 2014
- Practice Bulletin No. 137Obstetrics & Gynecology, 2013
- Glycine Normalizes Hepatic Triglyceride-Rich VLDL Secretion by Triggering the CNS in High-Fat Fed RatsCirculation Research, 2012
- Interplay between Lipids and Branched-Chain Amino Acids in Development of Insulin ResistanceCell Metabolism, 2012
- Emerging Perspectives on Essential Amino Acid Metabolism in Obesity and the Insulin-Resistant StateAdvances in Nutrition, 2011
- Differences in Maternal Circulating Fatty Acid Composition and Dietary Fat Intake in Women With Gestational Diabetes Mellitus or Mild Gestational HyperglycemiaDiabetes Care, 2010
- Defective Hepatic Autophagy in Obesity Promotes ER Stress and Causes Insulin ResistanceCell Metabolism, 2010
- Amino acids: metabolism, functions, and nutritionAmino Acids, 2009
- Glutamine and glutamate—their central role in cell metabolism and functionCell Biochemistry and Function, 2002